Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Beth

Apple’s second-generation HomePod is still too expensive and Siri too basic for it to shake up the smart home market, says GlobalData

Following Apple’s announcement of its second-generation HomePod smart speaker; Ardit Ballhysa, Technology Analyst at GlobalData, a leading data and analytics company, offers his view: “Apple’s second-generation HomePod offers no features that are not present in either the original HomePod or the HomePod Mini. Moreover, at $299, users will do well to avoid it, particularly during […]
Read more

Companies discussing ‘green technology’ in their filings increased by 5% in 2022, finds GlobalData

More than 2,400 companies discussed ‘green technology’ in their filings in 2022 amid climate change concerns and growing energy costs, according to GlobalData. The leading and data analytics company notes that this represents an increase of around 5% from 2021. Misa Singh, Analyst at GlobalData, comments: “Companies discussed a wide range of clean energy solutions, including photovoltaic […]
Read more

Leqembi’s prospects in the Alzheimer’s disease market remain uncertain despite its advantages over Aduhelm, says GlobalData

Eisai and Biogen’s anti-amyloid beta (Aβ) monoclonal antibody (mAb), Leqembi (lecanemab), recently gained approval from the Food and Drug Administration (FDA) under the accelerated approval pathway for the treatment of Alzheimer’s disease (AD) in patients with early AD. Achieving full approval will be crucial for Leqembi’s prospects as the US Centers for Medicare and Medicaid […]
Read more

Healthcare industry professionals’ optimism regarding pharma industry’s growth prospects is fading, finds GlobalData

The pharmaceutical industry is considered to be one of the most stable sectors even when pandemics, economic or geopolitical crises hit markets. However, even the pharmaceutical industry is not immune to the uncertainty in business conditions that 2023 may bring, finds GlobalData, a leading data and analytics company. A survey* taken from GlobalData’s report, ‘The State of the Biopharmaceutical Industry […]
Read more

GlobalData reveals its six telco consumer services, platforms and devices category predictions for 2023

If COVID-19 turned 2021 into a ‘difficult year’ for B2C telecommunications service providers, 2022 wasn’t much better. The unpredictable global geopolitical and economic backdrop, raging inflation, rising energy costs, and sharpened sustainability sensibilities make 2023 a challenging year to predict, says GlobalData. The leading data and analytics company’s latest report on what to expect in […]
Read more

Companies investing in key themes are taking the lead in the payments industry, says GlobalData

Disruptive solutions such as blockchain, artificial intelligence (AI) and cloud technology are creating new growth opportunities in the payments industry for companies that can capitalize on these trends. However, current economic market conditions such as inflation, high interest rate and cost of living will also present some challenges for the payments industry, especially for fintech […]
Read more

Genomics identified as the most impactful emerging pharmaceutical industry trend for 2023, according to GlobalData survey

Genomics will continue to play a significant role in helping to understand, prevent, and treat diseases throughout 2023. Coupled with continuous advancements in sequencing and data analyzing technologies, genomics holds the potential to enhance the speed of diagnosis and provide opportunities to personalize patient treatment approaches, says GlobalData, a leading data and analytics company. A survey […]
Read more

Global deal activity falls 9.9% in 2022 as several headwinds make it a tough year, finds GlobalData

Deal volume slowed significantly in 2022 as several global headwinds disrupted deal-making activities. A total of 66,155 deals* were announced globally during 2022, which is a decline of 9.9% over the 73,447 deals announced during the previous year, finds GlobalData, a leading data and analytics company. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “Factors such as the […]
Read more

Travel & tourism deal activity down by 3.4% in 2022, reveals GlobalData

A total of 1,006 deals* were announced in the global travel and tourism sector during the 2022, which is a decline of 3.4% over the 1,041 deals announced during the previous year, according to GlobalData, a leading data and analytics company. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “Geopolitical tensions and economic challenges seem to have impacted deal-making sentiments […]
Read more

Inflation, drug pricing and reimbursement constraints will have the biggest negative impact on biopharmaceutical industry in 2023, finds GlobalData

The biopharmaceutical industry has long been labelled as recession-proof, with stable demand for medicines and new treatment options acting as a protective barrier. Nevertheless, inflation, coupled with drug pricing and reimbursement constraints, will put high pressure on the biopharmaceutical industry’s growth prospects in 2023, says GlobalData, a leading data and analytics company. A survey by GlobalData*, […]
Read more

UK car sector faces weak recovery in 2023, says GlobalData

Following the release of data today by the Society of Motor Manufacturers and Traders (SMMT), showing that the UK new car market was down 2% at 1.61 million sales in 2022; David Leggett, Automotive Analyst at GlobalData, a leading data and analytics company, offers his view: “Major demand headwinds are building for UK households and […]
Read more
1 2 3 … 93